Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederinvestor.lilly.com
Get the latest updates from Eli Lilly and Company News Releases directly as they happen.
Follow now 229 followers
Last updated 6 days ago
6 days ago
EBGLYSS provides a new first-line biologic treatment for moderate-to-severe atopic dermatitis that...
7 days ago
Company ups manufacturing investment in Limerick by $1 billion ; unveils new...
9 days ago
Detailed results were published in The Lancet and simultaneously presented at the...
9 days ago
In QWINT-2, efsitora helped adults naïve to insulin therapy currently using and...
10 days ago
INDIANAPOLIS , Sept. 9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE...
14 days ago
In the phase 3 study, QWINT-1, efsitora was administered via four fixed...
15 days ago
Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to...
23 days ago
Distributed through LillyDirect ® 's self-pay channel, Zepbound single-dose vials are at...
28 days ago
INDIANAPOLIS , Aug. 22, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE...
about 1 month ago
176-week SURMOUNT-1 Phase 3 study in adults with pre-diabetes is the longest...
about 1 month ago
INDIANAPOLIS , Aug. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE...
about 1 month ago
Broadens Lilly's immunology pipeline with Morphic's oral integrin therapies, including MORF-057 Reinforces...